Join the debate on human genome editing!
By Yeyang Su,
Impact Ethics [cites CGS' Marcy Darnovsky]
| 11. 03. 2018
At the end of this month, the Second International Summit on Human Genome Editing will be held in Hong Kong. In the invitation to participants, the local host and President of the Academy of Sciences of Hong Kong, Dr Lap-Chee Tsui takes care to note that: “[o]f particular concern is the possibility of heritable genome editing… and applications for purposes other than to treat disease or disability.”
The possibility of heritable human genome editing is what propelled the United States National Academy of Sciences and National Academy of Medicine, United Kingdom’s Royal Society, and the Chinese Academy of Sciences to co-organize the First International Summit on Human Gene Editing three years ago, in Washington. This Summit was a response to the first published study in human embryos using CRISPR-Cas9 – then a newly discovered genome editing tool characterized by “unprecedented efficiency and stunning ease of use.”The research led by Junjiu Huang and Canquan Zhou at Sun Yat-sen University in Guangzhou, China, aimed to modify the endogenous β-globin gene that causes β-thalassaemia. β-thalassaemia affects about 2% of people in China, ...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...